IDXG - INTERPACE BIOSCIENCES, INC.

4.09
2.590   63.325%

Share volume: 0
Last Updated: 03-10-2021
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.50
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
18%
Profitability 8%
Dept financing 18%
Liquidity 12%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
17.14%
Key data
Stock price
$4.09
P/E Ratio 
7.47
DAY RANGE
N/A - N/A
EPS 
-$0.91
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
24.926 M
YIELD 
N/A
SHARES OUTSTANDING 
4.429 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Jack E. Stover
Region: US
Website: interpace.com
Employees: 90
IPO year: 2018
Issue type: Common Stock
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries.

Recent news